Abilify Dosage

For adults with schizophrenia who are first starting Abilify, dosing typically starts at 10 mg to 15 mg once daily. For the treatment of bipolar disorder, most people start with a daily dose of 30 mg. If needed, your healthcare provider may increase your dosage after two weeks or decrease your dosage if side effects occur. The recommended starting Abilify dose for treating major depression (when used along with an antidepressant) in adults is 2 mg to 5 mg once daily.
 

An Introduction to Abilify Dosage

The dose of Abilify® (aripiprazole) that your healthcare provider recommends will vary depending on a number of factors, including:
 
  • The medical condition being treated
  • Your age
  • The severity of your condition
  • Other medical conditions you may have
  • Other medications you may be currently taking.
     
As always, do not adjust your Abilify dose unless your healthcare provider specifically instructs you to do so.
 

Abilify Dosing for Schizophrenia

The recommended starting Abilify dose for schizophrenia in adults is 10 mg to 15 mg once daily. Your healthcare provider should not increase your Abilify dose more frequently than every two weeks, as it takes about two weeks for the medication to build up to a steady level in your body.
 
For adolescents age 13 to 17 years old, the recommended starting Abilify dose for schizophrenia is Abilify 2 mg once daily. Within a week or so, your healthcare provider should try to increase your dose to Abilify 10 mg once daily.
 

Abilify Dosing for Bipolar Disorder

The recommended starting dose of Abilify for bipolar disorder is 30 mg once daily. If you experience bothersome Abilify side effects, your healthcare provider may decrease your dose to Abilify 15 mg once daily.
 
For children and adolescents age 10 to 17 years old, the recommended starting Abilify dose for bipolar disorder is Abilify 2 mg once daily. Within a week or so, your healthcare provider should try to increase your dose to Abilify 10 mg once daily.
 
(Abilify Dosage Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;